DermaCol™ 100

• Maintains a moist wound environment that aids in the formation of granulation tissue and epithelialization
• High absorbency
• Exudate absorption inhibits protease activity by binding, inactivating and reducing the levels of MMPs at the wound site
• Collagen powder is easily distributed across the wound bed, enhancing surface area contact of the dressing
DermaCol™ 100 is indicated for the management of full- and partial-thickness wounds, including: pressure ulcers (I-IV), diabetic ulcers, venous ulcers, cuts and abrasions, mixed vascular ulcers, venous stasis ulcers, surgical wounds, and first- and second-degree burns.
Do not use on patients with a known allergy or sensitivity to bovine-derived materials.
For single use only.
Product is sterile and must not be re-sterilized.
This product has not been studied in pediatric populations and is intended only for use in adult patients.
Product remains sterile unless the package is opened or damaged.
Store in a cool, dry storage environment, <25°C. Keep away from sunlight.
Antimicrobial format available | |
Compatible w/ topicals | |
Conforms readily to wound | ● |
Cuttable | |
Flexible | |
Gels on contact w/ exudate | ● |
Limited shelf life | |
Moldable | |
Powder | ● |
Rope | |
Secondary dressing required | ● |
Silicone-based adhesive | |
Usable on infected wounds | |
Variety of sizes |
Educational Material Available | ● |
Free Samples/Trials Available | ● |
Published Clinical Article Available |
Acute Wounds
Burns
Chronic Wounds
Dehisced Wounds
Diabetic Foot
Moderate/Highly Exudating Wounds
Pressure Ulcers
Surgical Wounds
Venous Ulcers
DermaRite Industries manufactures and markets a full line of skin and wound care products and medical foods. Combined with its portfolio of tools and services, DermaRite offers practical solutions for prevention and treatment of skin breakdown.